Trademark Search in Canada

DAY ONE BIOPHARMACEUTICALS

View On IC.GC.CA

FORMALIZED

on 23 Feb 2024

Last Applicant/ Owned by

Day One Biopharmaceuticals, Inc.

1800 Sierra Point Parkway, Suite 200Brisbane, CA 94005

Serial Number

2312144 filed on 23^rd Feb 2024

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

DAY ONE BIOPHARMACEUTICALS

Trademark usage description

pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmac Read More

Classification Information

Class [005]
Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders.

Classification kind code

Class [042]
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders.

Classification kind code

Class [044]
Medical information services; healthcare services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; healthcare services, namely, wellness and disease management programs; providing clinical information and support services regarding prescription drugs and treatment of disease; providing medical information regarding the treatment, and diagnosis of diseases; healthcare patient support services by means of a call center; providing patient support services, namely, providing patient check-up services in the form of reminders, wellness trackers, and patient and caregiver wellness check-ups; providing a website featuring health information in the field of tumors and cancer.

Classification kind code

Mark Details

Serial Number

2312144

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 135 on 17^th Jan 2025	Amendment to Application
Submitted for opposition 287 on 7^th Mar 2024	Pre-Assessment Letter Sent
Submitted for opposition 30 on 23^rd Feb 2024	Filed
Submitted for opposition 1 on 23^rd Feb 2024	Created
Submitted for opposition 31 on 23^rd Feb 2024	Formalized